These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


92 related items for PubMed ID: 12037376

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Melatonin inhibits the central sympatho-adrenomedullary outflow in rats.
    Wang M, Yokotani K, Nakamura K, Murakami Y, Okada S, Osumi Y.
    Jpn J Pharmacol; 1999 Sep; 81(1):29-33. PubMed ID: 10580367
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Vasopressin V(1) receptor-mediated activation of central sympatho-adrenomedullary outflow in rats.
    Okada S, Murakami Y, Nakamura K, Yokotani K.
    Eur J Pharmacol; 2002 Dec 13; 457(1):29-35. PubMed ID: 12460640
    [Abstract] [Full Text] [Related]

  • 6. Role of brain adrenoceptors in the corticortopin-releasing factor-induced central activation of sympatho-adrenomedullary outflow in rats.
    Yorimitsu M, Okada S, Yamaguchi-Shima N, Shimizu T, Arai J, Yokotani K.
    Life Sci; 2008 Feb 27; 82(9-10):487-94. PubMed ID: 18201726
    [Abstract] [Full Text] [Related]

  • 7. Role of brain arachidonic acid cascade on central CRF1 receptor-mediated activation of sympatho-adrenomedullary outflow in rats.
    Yokotani K, Murakami Y, Okada S, Hirata M.
    Eur J Pharmacol; 2001 May 11; 419(2-3):183-9. PubMed ID: 11426840
    [Abstract] [Full Text] [Related]

  • 8. Roles of brain prostaglandin E2 and thromboxane A2 in the activation of the central sympatho-adrenomedullary outflow in rats.
    Murakami Y, Okada S, Nishihara M, Yokotani K.
    Eur J Pharmacol; 2002 Oct 11; 452(3):289-94. PubMed ID: 12359269
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of centrally administered prostaglandin E(3) and thromboxane A(3) on plasma noradrenaline and adrenaline in rats: comparison with prostaglandin E(2) and thromboxane A(2).
    Shimizu T, Yokotani K.
    Eur J Pharmacol; 2009 Jun 02; 611(1-3):30-4. PubMed ID: 19344706
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Centrally administered N-methyl-d-aspartate evokes the adrenal secretion of noradrenaline and adrenaline by brain thromboxane A2-mediated mechanisms in rats.
    Okada S, Yamaguchi-Shima N, Shimizu T, Arai J, Yorimitsu M, Yokotani K.
    Eur J Pharmacol; 2008 May 31; 586(1-3):145-50. PubMed ID: 18374330
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.